Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
- PMID: 29512598
- PMCID: PMC5861467
- DOI: 10.4103/ijmr.IJMR_1354_17
Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
Abstract
Breast cancer is a heterogeneous disease and may present with different clinical and biological characteristics. At present, breast cancer is divided into molecular subgroups besides its histopathological classification. Decision for adjuvant chemotherapy is made based on not only histopathological characteristics but also molecular and genomic characteristics using indices, guidelines and calculators in early-stage breast cancer. Making a treatment plan through all these prognostic and predictive methods according to risk categories aims at preventing unnecessary or useless treatments. In this review, an attempt to make a general assessment of prognostic and predictive methods is made which may be used for planning individualized therapy and also the comments of the guidelines used by the oncologists worldwide on these methods.
Keywords: Adjuvant chemotherapy - early-stage breast cancer - predictive - prognostic.
Conflict of interest statement
None.
Similar articles
-
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial.Ann Oncol. 2016 Jun;27(6):1035-1040. doi: 10.1093/annonc/mdw070. Epub 2016 Feb 18. Ann Oncol. 2016. PMID: 27022068 Clinical Trial.
-
Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.Breast Cancer Res Treat. 2018 Jul;170(1):69-76. doi: 10.1007/s10549-018-4740-z. Epub 2018 Mar 8. Breast Cancer Res Treat. 2018. PMID: 29516374
-
Tailoring Chemotherapy in Early-Stage Breast Cancer: Based on Tumor Biology or Tumor Burden?Am Soc Clin Oncol Educ Book. 2016;35:e31-8. doi: 10.1200/EDBK_159077. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249737 Review.
-
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer.Breast Cancer Res Treat. 2019 Jun;175(3):617-625. doi: 10.1007/s10549-019-05198-9. Epub 2019 Mar 13. Breast Cancer Res Treat. 2019. PMID: 30868391
-
Predicting endocrine therapy responsiveness in breast cancer.Oncology (Williston Park). 2009 Feb;23(2):133-42. Oncology (Williston Park). 2009. PMID: 19323294 Review.
Cited by
-
Prognostic significance of serum lactate dehydrogenase in patients with breast cancer: a meta-analysis.Cancer Manag Res. 2019 Apr 26;11:3611-3619. doi: 10.2147/CMAR.S199260. eCollection 2019. Cancer Manag Res. 2019. PMID: 31118783 Free PMC article.
-
The functional TNF-α-308G > a single-nucleotide polymorphism (rs1800629): association with the predictive indices of breast cancer carcinogenesis.Breast Cancer Res Treat. 2025 Feb;210(1):57-70. doi: 10.1007/s10549-024-07536-y. Epub 2024 Nov 21. Breast Cancer Res Treat. 2025. PMID: 39570546 Free PMC article.
-
Prognostic significance of ER-to-PR difference in ER+/HER2- early breast cancer.Sci Rep. 2024 Oct 18;14(1):24431. doi: 10.1038/s41598-024-74608-w. Sci Rep. 2024. PMID: 39424816 Free PMC article.
-
Amplification of Stem Genes: New Potential Metastatic Makers in Patients with an Early Form of Breast Cancer.J Korean Med Sci. 2019 Dec 23;34(49):e312. doi: 10.3346/jkms.2019.34.e312. J Korean Med Sci. 2019. PMID: 31858753 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 Lyon. France: International Agency for Research on Cancer; 2013.
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Nagao T, Kinoshita T, Hojo T, Tsuda H, Tamura K, Fujiwara Y, et al. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: The relationship between the outcome and the clinicopathological characteristics. Breast. 2012;21:289–95. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous